Table 1.
Indication | TJLB | PLB | LLB |
---|---|---|---|
Indeterminate liver disease (n) | 45 (44%) | 32 (32%) | 38 (34%) |
Acute/subacute liver failure (n) | 32 (31%) | 1 (1%) | 0 (0%) |
Chronic hepatitis | 12 (12%) | 43 (43%) | 24 (21%) |
LFT elevation after OLT (n) | 11 (11%) | 19 (19%) | 0 (0%) |
Others (n) | 2 (2%) | 5 (5%) | 50 (45%) |
Total (n) | 102 | 100 | 112 |